IMPACT Therapeutics has received the China National Medical Products Administration (NMPA) marketing authorisation for ...

High heat shock protein 60 (HSP60) expression in patients with ovarian cancer is associated with larger tumors, advanced ...

Background: Variable rates of HER2 protein overexpression and gene amplification have been reported in advanced ovarian ... [FISH] positive) ovarian cancer progressing under taxane/carboplatin ...

IMPACT Therapeutics ('IMPACT'), a biopharmaceutical company focusing on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality, is pleased to announce that ...

New data from proof-of-concept study provides roadmap for treatment of ovarian cancerCAMBRIDGE, Mass., Jan. 14, 2025 (GLOBE ...

Epithelial ovarian cancer is the fourth biggest cause of cancer-related death in women. Over recent decades, improvements have been made in treatment outcome in terms of response rate and survival.

Cervical and ovarian cancers affect the female reproductive system. To avoid any confusion between ovarian vs cervical cancer ...

A new pathway to fast track patients from the Preston area with suspected ovarian cancer is being implemented at the Royal ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical ...

Cytoreductive surgery, whether performed as the initial treatment or following neoadjuvant chemotherapy (NACT) for advanced ...

The FDA has granted fast track designation to emiltatug ledadotin for advanced or metastatic breast cancer treatment, as ...

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...